Farrukh T. Awan

Farrukh T. Awan, MD, MS, MBA

Associate Director, Section of Hematologic Malignancies/Transplantation and Cellular Therapy
Director of Lymphoid Malignancies Program
Harold C. Simmons Comprehensive Cancer Center
University of Texas Southwestern Medical Center
Dallas, Texas

Explore Activities by Farrukh T. Awan

Title
Format
Credit Type
Credits
Community Practice Grand Rounds: Experts Explore the Latest Evidence and Guideline Updates in Chronic Lymphocytic Leukemia

Content Format:

Slideset

Credit Type:

--

Credits:

--
Answering Key Questions in the Optimal Treatment for Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia

Content Format:

Clinical Thought

Credit Type:

AMA

Credits:

0.25
Répondre aux questions clés concernant le traitement optimal des patients atteints de leucémie lymphoïde chronique récurrente ou réfractaire

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Risposte alle domande chiave sul trattamento ottimale per i pazienti con leucemia linfatica cronica recidivata/refrattaria

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Respondendo a perguntas-chave sobre o tratamento ideal para doentes com leucemia linfocítica crónica recaída/refratária

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Responder a las preguntas clave en el tratamiento óptimo de los pacientes con leucemia linfocítica crónica recidivante/refractaria

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Beantwortung wichtiger Fragen zur optimalen Behandlung von Patientinnen und Patienten mit rezidivierter/refraktärer chronischer lymphatischer Leukämie

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Optimal Therapeutic Sequencing in Relapsed/Refractory CLL for Physicians

Content Format:

Video

Credit Type:

AMA

Credits:

1.25
Optimal Therapeutic Sequencing in Relapsed/Refractory CLL: A Global Perspective

Content Format:

Slideset

Credit Type:

AMA

Credits:

1.00
Individualizing CLL Therapy: Second-Line Treatment and Beyond

Content Format:

Text Module

Credit Type:

AMA

Credits:

0.75
Individualizing CLL Therapy: Second-Line Treatment and Beyond

Content Format:

Slideset

Credit Type:

--

Credits:

--
Individualizing CLL Therapy: Frontline Treatment

Content Format:

Slideset

Credit Type:

--

Credits:

--
Individualizing CLL Therapy: Frontline Treatment

Content Format:

Text Module

Credit Type:

AMA

Credits:

0.75
Interactive Tool for Managing Adverse Events Associated With BCL-2 Inhibitors in Hematologic Malignancies

Content Format:

Tool

Credit Type:

--

Credits:

--
Expert Guidance for the Treatment of CLL

Content Format:

Tool

Credit Type:

--

Credits:

--
Current Clinical Practice and NCCN Guidelines for CLL/SLL

Content Format:

Podcast Episodes

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

0.50
Aligning Current Clinical Practice With NCCN CLL/SLL Guidelines

Content Format:

Slideset

Credit Type:

--

Credits:

--